Description

LML4801 Assignment 2 Semester 1 Memo | Due 25 April 2025. All questions fully answered. Scenario Peter works for Pharmabayu Inc in South Africa, as a researcher testing various dosage regimes of known and new pharmaceutical compounds. While on holiday, he devises a new dosage regime for an existing pharmaceutical compound known to be used in cardiac arrythmia management medicine since 2004. Pharmabayu applies for a patent for which the patent claim for the patent (granted on 5 August 2023) reads as follows: ‘The use of the compound (maxorevo) for the manufacture of a medicament in an oral dosage form for the treatment of cardiac disorders for administration no more than once daily for at least seven consecutive days, where said compound has a plasma concentration half-life of 12 hours or less when orally administered to a human patient, wherein the cardiac disorder is arrhythmia, and wherein the oral dosage form is a rapid-release tablet.’ A rival pharmaceutical firm, R.D. Gen, decides to apply for the revocation of this patent to bring their own cardiac arrythmia medicine (which also makes use of maxorevo) to market. The maxorevo compound was first identified in March 2001.  Question 1 1. Outline the potentially viable revocation grounds that R.D. Gen might rely on for this application and comment on the likelihood of success for each ground.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Description

LML4801 Assignment 2 Semester 1 Memo | Due 25 April 2025. All questions fully answered. Scenario Peter works for Pharmabayu Inc in South Africa, as a researcher testing various dosage regimes of known and new pharmaceutical compounds. While on holiday, he devises a new dosage regime for an existing pharmaceutical compound known to be used in cardiac arrythmia management medicine since 2004. Pharmabayu applies for a patent for which the patent claim for the patent (granted on 5 August 2023) reads as follows: ‘The use of the compound (maxorevo) for the manufacture of a medicament in an oral dosage form for the treatment of cardiac disorders for administration no more than once daily for at least seven consecutive days, where said compound has a plasma concentration half-life of 12 hours or less when orally administered to a human patient, wherein the cardiac disorder is arrhythmia, and wherein the oral dosage form is a rapid-release tablet.’ A rival pharmaceutical firm, R.D. Gen, decides to apply for the revocation of this patent to bring their own cardiac arrythmia medicine (which also makes use of maxorevo) to market. The maxorevo compound was first identified in March 2001.  Question 1 1. Outline the potentially viable revocation grounds that R.D. Gen might rely on for this application and comment on the likelihood of success for each ground.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

31
    31
    Your Shopping Cart
    IOP3706 ASSIGNMENT 01 MEMO SEMESTER 1 2024
    IOP3706 ASSIGNMENT 01 MEMO SEMESTER 1 2024
    Seller:

    Andre

    Price: R50.00
    R50.00
    LJU4801 ASSIGNMENT 01 MEMO SEMESTER 2 2023
    LJU4801 ASSIGNMENT 01 MEMO SEMESTER 2 2023
    Seller:

    Andre

    Price: R50.00
    R50.00
    LML4807 Exam Pack with great notes!
    LML4807 Exam Pack with great notes!
    Seller:

    Mbali Law Tutor

    Price: R85.00
    R85.00
    PLC2602 ASSIGNMENT 01 SOLUTIONS SEMESTER 1 2024
    R50.00
    LLW2602 ASSIGNMENT 01 MEMO SEMESTER 2 2023
    LLW2602 ASSIGNMENT 01 MEMO SEMESTER 2 2023
    Seller:

    Andre

    Price: R50.00
    R50.00
    TPS2601 Assignment 2 2023 Unique Number: 743441 Due Date: 28 September 2023 (Well Complete Answers)
    R60.00
    TLI4801 ASSIGNMENT 01 MEMO SEMESTER 1 2024
    TLI4801 ASSIGNMENT 01 MEMO SEMESTER 1 2024
    Seller:

    Andre

    Price: R50.00
    R50.00
    TLI4801 Assignment 1 answers
    TLI4801 Assignment 01 Answers Semester 1 2025
    Seller:

    Andre

    Price: R50.00
    R50.00
    PVL3704 ASSIGNMENT 01 MEMO SEMESTER 1 2024
    PVL3704 ASSIGNMENT 01 MEMO SEMESTER 1 2024
    Seller:

    Andre

    Price: R50.00
    R50.00
    ENN1504 Assignment 1 Semester 1 2024
    ENN1504 Assignment 1 Semester 1 2024
    Seller:

    Aimark94

    Price: R50.00
    R50.00